All Title Author
Keywords Abstract

PLOS ONE  2014 

1H NMR-Based Metabolite Profiling of Plasma in a Rat Model of Chronic Kidney Disease

DOI: 10.1371/journal.pone.0085445

Full-Text   Cite this paper   Add to My Lib


Chronic kidney disease (CKD) is characterized by the gradual loss of the kidney function to excrete wastes and fluids from the blood. 1H NMR-based metabolomics was exploited to investigate the altered metabolic pattern in rats with CKD induced by surgical reduction of the renal mass (i.e., 5/6 nephrectomy (5/6 Nx)), particularly for identifying specific metabolic biomarkers associated with early of CKD. Plasma metabolite profiling was performed in CKD rats (at 4- or 8-weeks after 5/6 Nx) compared to sham-operated rats. Principle components analysis (PCA), partial least squares-discriminant analysis (PLS-DA) and orthogonal partial least squares-discriminant analysis (OPLS-DA) score plots showed a significant separation between the groups. The resulting metabolic profiles demonstrated significantly increased plasma levels of organic anions, including citrate, β-hydroxybutyrate, lactate, acetate, acetoacetate, and formate in CKD. Moreover, levels of alanine, glutamine, and glutamate were significantly higher. These changes were likely to be associated with complicated metabolic acidosis in CKD for counteracting systemic metabolic acidosis or increased protein catabolism from muscle. In contrast, levels of VLDL/LDL (CH2)n and N-acetylglycoproteins were decreased. Taken together, the observed changes of plasma metabolite profiles in CKD rats provide insights into the disturbed metabolism in early phase of CKD, in particular for the altered metabolism of acid-base and/or amino acids.


[1]  Bouby N, Hassler C, Parvy P, Bankir L (1993) Renal synthesis of arginine in chronic renal failure: in vivo and in vitro studies in rats with 5/6 nephrectomy. Kidney Int 44: 676–676.
[2]  RJ A, editor (2000) The kidney.6th: W.B. WB saunders Co. 455–519 p.
[3]  Zhao YY, Liu J, Cheng XL, Bai X, Lin RC (2011) Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS. Clin Chim Acta 413: 642–649.
[4]  Weiner ID, Verlander JW, Wingo CS (2011) Renal acidification mechanisms. Core Concepts in the Disorders of Fluid, Electrolytes and Acid-Base Balance: 203–233.
[5]  Kraut JA, Kurtz I (2005) Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment. Am J Kidney Dis 45: 978–993.
[6]  Roderick P, Willis N, Blakeley S, Jones C, Tomson C (2007) Correction of chronic metabolic acidosis for chronic kidney disease patients. Cochrane Database Syst Rev 1: CD001890.
[7]  Kovesdy CP, Anderson JE, Kalantar-Zadeh K (2009) Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD. Nephrol Dial Transplant 24: 1232–1237.
[8]  Charles JC, Heilman RL (2005) Metabolic acidosis. Hospital Physician 41: 37–42.
[9]  Adeva MM, Souto G (2011) Diet-induced metabolic acidosis. Clin Nutr 30: 416–421.
[10]  Farber M, Szwed J, Dowell A, Strawbridge R (1976) The acute effects of respiratory and metabolic acidosis on renal function in the dog. Clin Sci Mol Med 50: 165–169.
[11]  de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM (2009) Bicarbonate supplementation slows progression of CKD and improves nutritional status. JASN 20: 2075–2084.
[12]  Choi J-Y, Yoon YJ, Choi H-J, Park S-H, Kim C-D, et al. (2011) Dialysis modality-dependent changes in serum metabolites: accumulation of inosine and hypoxanthine in patients on haemodialysis. Nephrol Dial Transplant 26: 1304–1313.
[13]  Hwang GS, Yang JY, Ryu DH, Kwon TH (2010) Metabolic profiling of kidney and urine in rats with lithium-induced nephrogenic diabetes insipidus by 1H-NMR-based metabonomics. Am J Physiol Renal Physiol 298: F461–F470.
[14]  Jang ZH, Chung HC, Ahn YG, Kwon YK, Kim JS, et al. (2012) Metabolic profiling of an alcoholic fatty liver in zebrafish (Danio rerio). Mol BioSyst 8: 2001–2009.
[15]  Jung JY, Lee HS, Kang DG, Kim NS, Cha MH, et al. (2011) 1H-NMR-based metabolomics study of cerebral infarction. Stroke 42: 1282–1288.
[16]  Kirschenlohr HL, Griffin JL, Clarke SC, Rhydwen R, Grace AA, et al. (2006) Proton NMR analysis of plasma is a weak predictor of coronary artery disease. Nat Med 12: 705–710.
[17]  Schicho R, Shaykhutdinov R, Ngo J, Nazyrova A, Schneider C, et al. (2012) Quantitative Metabolomic Profiling of Serum, Plasma, and Urine by 1H NMR Spectroscopy Discriminates between Patients with Inflammatory Bowel Disease and Healthy Individuals. J Proteome Res 11: 3344–3357.
[18]  Kim CD, Kim EY, Yoo H, Lee JW, Ryu DH, et al. (2010) Metabonomic analysis of serum metabolites in kidney transplant recipients with cyclosporine A-or tacrolimus-based immunosuppression. Transplantation 90: 748–756.
[19]  Choi H-J, Yoon Y-J, Kwon Y-K, Lee Y-J, Chae S, et al. (2012) Patterns of Gene and Metabolite Define the Effects of Extracellular Osmolality on Kidney Collecting Duct. J Proteome Res 11: 3816–3828.
[20]  Kwon TH, Fr?kiaer J, Fernández-Llama P, Maunsbach AB, Knepper MA, et al. (1999) Altered expression of Na transporters NHE-3, NaPi-II, Na-K-ATPase, BSC-1, and TSC in CRF rat kidneys. Am J Physiol Renal Physiol 277: F257–F270.
[21]  Kwon TH, Fr?kiaer J, Knepper MA, Nielsen S (1998) Reduced AQP1,-2, and-3 levels in kidneys of rats with CRF induced by surgical reduction in renal mass. Am J Physiol Renal Physiol 275: F724–F741.
[22]  Efron B, Gong G (1983) A leisurely look at the bootstrap, the jackknife, and cross-validation. Am Stat 37: 36–48.
[23]  Somashekar BS, Amin AG, Tripathi P, MacKinnon N, Rithner CD, et al. (2012) Metabolomic signatures in guinea pigs infected with epidemic-associated W-Beijing strains of Mycobacterium tuberculosis. J Proteome Res 11: 4873–4884.
[24]  Hong YS, Ahn YT, Park JC, Lee JH, Lee H, et al. (2010) 1 H NMR-based metabonomic assessment of probiotic effects in a colitis mouse model. Arch Pharm Res 33: 1091–1101.
[25]  Shin JH, Yang JY, Jeon BY, Yoon YJ, Cho SN, et al. (2011) 1H NMR-based metabolomic profiling in mice infected with Mycobacterium tuberculosis. J Proteome Res 10: 2238–2247.
[26]  Soininen P, Kangas AJ, Würtz P, Tukiainen T, Tynkkynen T, et al. (2009) High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst 134: 1781–1785.
[27]  Alpern R (1990) Cell mechanisms of proximal tubule acidification. Physiol Rev 70: 79–114.
[28]  Boron WF, Boulpaep EL (1983) Intracellular pH regulation in the renal proximal tubule of the salamander. Basolateral HCO3-transport. J Gen Physiol 81: 53–94.
[29]  Romero MF, Hediger MA, Boulpaep EL, Boron WF (1997) Expression cloning and characterization of a renal electrogenic Na+/HCO3? cotransporter. Nature 387: 409–413.
[30]  Boron WF (2006) Acid-base transport by the renal proximal tubule. JASN 17: 2368–2382.
[31]  Laing CM, Toye AM, Capasso G, Unwin RJ (2005) Renal tubular acidosis: developments in our understanding of the molecular basis. Int J Biochem Cell Biol 37: 1151–1161.
[32]  Hamm LL (1990) Renal handling of citrate. Kidney Int 38: 728–735.
[33]  Choi I, Aalkjaer C, Boulpaep EL, Boron WF (2000) An electroneutral sodium/bicarbonate cotransporter NBCn1 and associated sodium channel. Nature 405: 571–575.
[34]  Kwon TH, Fulton C, Wang W, Kurtz I, Fr?kiaer J, et al. (2002) Chronic metabolic acidosis upregulates rat kidney Na-HCO3- cotransporters NBCn1 and NBC3 but not NBC1. Am J Physiol Renal Physiol 282: F341–F351.
[35]  Vorum H, Kwon TH, Fulton C, Simonsen B, Choi I, et al. (2000) Immunolocalization of electroneutral Na-HCO3? cotransporter in rat kidney. Am J Physiol Renal Physiol 279: F901–F909.
[36]  Maddox DA, Horn JF, Famiano FC, Gennari FJ (1986) Load dependence of proximal tubular fluid and bicarbonate reabsorption in the remnant kidney of the Munich-Wistar rat. J Clin Invest 77: 1639–1649.
[37]  Tanner GA, Tanner JA (2000) Citrate therapy for polycystic kidney disease in rats. Kidney Int 58: 1859–1869.
[38]  Alpern RJ (1995) Trade-offs in the adaptation to acidosis. Kidney Int 47: 1205–1215.
[39]  Brennan S, Hering-Smith K, Hamm L (1988) Effect of pH on citrate reabsorption in the proximal convoluted tubule. Am J Physiol Renal Physiol 255: F301–F306.
[40]  Jenkins AD, Dousa TP, Smith LH (1985) Transport of citrate across renal brush border membrane: effects of dietary acid and alkali loading. Am J Physiol Renal Physiol 249: F590–F595.
[41]  Condon J, Asatoor A (1971) Amino acid metabolism in uraemic patients. Clin Chim Acta 32: 333–337.
[42]  Garber A, Karl I, Kipnis D (1976) Alanine and glutamine synthesis and release from skeletal muscle. I. Glycolysis and amino acid release. J Biol Chem 251: 826–835.
[43]  Garber AJ (1978) Skeletal muscle protein and amino acid metabolism in experimental chronic uremia in the rat: accelerated alanine and glutamine formation and release. J Clin Invest 62: 623–632.
[44]  May R, Kelly R, Mitch W (1986) Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. J Clin Invest 77: 614–621.
[45]  May R, Kelly R, Mitch W (1987) Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. Influence of metabolic acidosis. J Clin Invest 79: 1099–1103.
[46]  Garber AJ (1978) The regulation of skeletal muscle alanine and glutamine formation and release in experimental chronic uremia in the rat: subsensitivity of adenylate cyclase and amino acid release to epinephrine and serotonin. J Clin Invest 62: 633–641.


comments powered by Disqus